Publications scientifiques en 2023

Depuis le 02/06/2023
  1. Adverse drug reaction related to drug shortage: A retrospective study on the French National Pharmacovigilance Database.
    Bourneau-Martin D, Babin M, Grandvuillemin A, Mullet C, Salvo F, Singier A, Cellier M, Fresse A, de Canecaude C, Pietri T, Drablier G, Geniaux H, Lagarce L, Laroche ML, Briet M; French Network of Regional Pharmacovigilance Centres.
    Br J Clin Pharmacol. 2023
  2. Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
    Benaboud S, Solas C, Bouchet S, Gregoire M, Lemaitre F, Venisse N, Lê MP, Muret P, Parant F, Neant N, Boujafaar S, Lagoutte-Renosi J, Garraffo R, Peytavin G.
    J Antimicrob Chemother. 2023
  3. Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.
    Hyeraci G, Gini R, Bezin J, Iannone LF, Benemei S, Lupi C, De Cesaris F, Geppetti P, Roberto G.
    Headache. 2023
  4. [Analyze and use the results of clinical studies in the perspective of good use. Critical analysis, clinical research and levels of evidence]
    Pariente A, de Germay S.
    Rev Prat. 2023
  5. Drugs and the elderly: A complex interaction.
    Bégaud B, de Germay S, Noize P.
    Therapie. 2023
  6. [Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice]
    de Germay S, Conte C, Micallef J, Bouquet E, Chouchana L, Lafaurie M, Pariente A; au nom du groupe de pharmaco-épidémiologie de la Société Française de Pharmacologie et de Thérapeutique (SFPT).
    Therapie. 2023
  7. Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice.
    de Germay S, Conte C, Micallef J, Bouquet E, Chouchana L, Lafaurie M, Pariente A; Pharmacoepidemiological group of the French Society of Pharmacology and Therapeutics (SFPT).
    Therapie. 2023
  8. Alprazolam misuse: Analysis of French Addictovigilance Network data from 2011 to 2020.
    Diaz L, Eiden C, Jouanjus E, Frauger E, Fouilhé N, Djezzar S, Gibaja V, Boucher A, Le Boisselier R, Libert F, Caous AS, Monzon E, Guerlais M, Daveluy A, Fauconneau B, Peyrière H.
    Therapie. 2023
  9. Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran).
    Valnet-Rabier MB, Tebacher M, Gautier S, Micallef J, Salvo F, Pariente A, Bagheri H.
    Therapie. 2023
  10. Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
    Pariente A.
    Therapie. 2023
  11. Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspective.
    Salvo F, Pariente A, Valnet-Rabier MB, Drici MD, Cholle C, Mathieu C, Singier A, Bagheri H, Tebacher M, Micallef J, Gautier S; French Network of Regional Pharmacovigilance Centers.
    Therapie. 2023
  12. Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study.
    Létinier L, Bezin J, Jarne A, Pariente A.
    Drug Saf. 2023
  13. The ongoing structuring of human papillomavirus (HPV) vaccination in middle schools in Nouvelle-Aquitaine, France.
    Quelet S, Valadeau C, Héron-Rougier C, Pariente A, Gault G, Elleboode B.
    Infect Dis Now. 2023
  14. Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390.
    Bezin J, Mathieu C, Faillie JL, Pariente A.
    Diabetes Care. 2023
  15. Nitrous oxide: a unique official French addictovigilance national survey.
    Guerlais M, Aquizerate A, Lionnet A, Daveluy A, Duval M, Gérardin M, Istvan M, Laforgue EJ, Victorri-Vigneau C.
    Front Public Health. 2023
  16. Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase®).
    Duga AL, Salvo F, Kay A, Figueras A.
    Antibiotics (Basel). 2023